These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 884316)

  • 1. Plasma thromboplastin antecedent (PTA, factor XI): a specific and sensitive radioimmunoassay.
    Saito H; Goldsmith GH
    Blood; 1977 Sep; 50(3):377-85. PubMed ID: 884316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay of human Hageman factor (factor XII).
    Saito H; Ratnoff OD; Pensky J
    J Lab Clin Med; 1976 Sep; 88(3):506-14. PubMed ID: 956701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease.
    Saito H; Poon MC; Vicic W; Goldsmith GH; Menitove JE
    J Lab Clin Med; 1978 Jul; 92(1):84-95. PubMed ID: 659966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.
    Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F
    J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation.
    Saito H; Ratnoff OD
    Adv Exp Med Biol; 1979; 120B():61-70. PubMed ID: 517254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of high molecular weight kininogen and the role of this agent in blood coagulation.
    Saito H
    J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on plasma thromboplastin antecedent (factor XI), PTA deficiency and inhibition of PTA by plasma: pharmacologic inhibitors and specific antiserum.
    Forbes CD; Ratnoff OD
    J Lab Clin Med; 1972 Jan; 79(1):113-27. PubMed ID: 4257309
    [No Abstract]   [Full Text] [Related]  

  • 8. Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.
    Donaldson VH; Kleniewski J; Saito H; Sayed JK
    J Clin Invest; 1977 Sep; 60(3):571-83. PubMed ID: 893663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amidolytic assay of human factor XI in plasma: comparison with a coagulant assay and a new rapid radioimmunoassay.
    Scott CF; Sinha D; Seaman FS; Walsh PN; Colman RW
    Blood; 1984 Jan; 63(1):42-50. PubMed ID: 6606454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin.
    Saito H; Ratnoff OD; Marshall JS; Pensky J
    J Clin Invest; 1973 Apr; 52(4):850-61. PubMed ID: 4266422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contact factors in health and disease.
    Saito H
    Semin Thromb Hemost; 1987 Jan; 13(1):36-49. PubMed ID: 3551076
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of Hageman factor (HG, factor XII) and plasma prekallikrein (Fletcher factor) by radioimmunoassays.
    Saito H
    Adv Exp Med Biol; 1979; 120A():165-72. PubMed ID: 573961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood kinins, their concentration in normal subjects and in patients with congenital deficiency in plasma prekallikrein and kininogen.
    Scicli AG; Mindroiu T; Scicli G; Carretero OA
    J Lab Clin Med; 1982 Jul; 100(1):81-93. PubMed ID: 6919569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unique precipitating autoantibody against plasma thromboplastin antecedent associated with multiple apparent plasma clotting factor deficiencies in a patient with systemic lupus erythematosus.
    Poon MC; Saito H; Koopman WJ
    Blood; 1984 Jun; 63(6):1309-17. PubMed ID: 6426550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XI (PTA) deficiency. Surgical and obstetric aspects.
    Purcell G; Nossel HL
    Obstet Gynecol; 1970 Jan; 35(1):69-74. PubMed ID: 5409837
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunoelectrophoretic studies of prekallikrein in human plasma.
    Hathaway WE; Christian J; McGregor R; Borden C
    Thromb Res; 1982 Feb; 25(3):267-75. PubMed ID: 6917563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of factor XI analysis in blood coagulation tests].
    Saito H
    Nihon Rinsho; 1989 Dec; 48 Suppl():840-2. PubMed ID: 2622015
    [No Abstract]   [Full Text] [Related]  

  • 19. [Coagulation and fibrinolysis associated with contact phase in plasma with high molecular weight kininogen deficiency].
    Iijima K; Nakamura K
    Rinsho Ketsueki; 1989 Oct; 30(10):1702-7. PubMed ID: 2593236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Artificial deficient plasma for the determination of the activity of coagulation factor XI].
    Lutze G; Dieckmann U; Urbahn H
    Z Med Lab Diagn; 1984; 25(8):427-31. PubMed ID: 6523998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.